Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 1.00 |
| ▸ | CA12 | O43570 | 2/20 | 1.00 |
| ▸ | CA1 | P00915 | 2/20 | 1.00 |
| ▸ | CA2 | P00918 | 2/20 | 1.00 |
| ▸ | CA7 | P43166 | 2/20 | 1.00 |
| ▸ | CA9 | Q16790 | 2/20 | 1.00 |
| ▸ | APAF1 | O14727 | 1/20 | 1.00 |
| ▸ | MAPK1 | P28482 | 1/20 | 1.00 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 1.00 |
| ▸ | CA13 | Q8N1Q1 | 1/20 | 1.00 |
| ▸ | PDE4D | Q08499 | 2/20 | 0.40 |
| ▸ | HIF1A | Q16665 | 4/20 | 0.35 |
| ▸ | EPAS1 | Q99814 | 4/20 | 0.35 |
| ▸ | HCAR2 | Q8TDS4 | 3/20 | 0.33 |
| ▸ | TSSK1B | Q9BXA7 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| (+)-Calanolide B SCHEMBL212038 | 1.00 | ALDH1A1 (1.00) | ALDH1A1CA12CA1CA2CA7 | |
| Calanolide C SCHEMBL7036135 | 1.00 | ALDH1A1 (1.00) | ALDH1A1CA12CA1CA2CA7 | |
| Costatolide SCHEMBL30544160 | 1.00 | ALDH1A1 (1.00) | ALDH1A1CA12CA1CA2CA7 | |
| (-)-Calanolide A SCHEMBL29803798 | 1.00 | ALDH1A1 (1.00) | ALDH1A1CA12CA1CA2CA7 | |
| Calanolide A SCHEMBL140017 | 1.00 | ALDH1A1 (1.00) | ALDH1A1CA12CA1CA2CA7 | |
| (-)-Calanolide A SCHEMBL8927754 | 1.00 | ALDH1A1 (1.00) | ALDH1A1CA12CA1CA2CA7 | |
| Costatolide SCHEMBL29397227 | 1.00 | ALDH1A1 (1.00) | ALDH1A1CA12CA1CA2CA7 | |
| Costatolide SCHEMBL29402951 | 1.00 | ALDH1A1 (1.00) | ALDH1A1CA12CA1CA2CA7 | |
| Costatolide SCHEMBL8927756 | 1.00 | ALDH1A1 (1.00) | ALDH1A1CA12CA1CA2CA7 | |
| SCHEMBL19596735 | 0.90 | ALDH1A1 (0.82) | ALDH1A1CA12CA1CA2CA7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4556010-A2 | JAK INHIBITORS FOR USE IN THE PREVENTION OR TREATMENT OF A VIRAL DISEASE CAUSED BY A CORONAVIRIDAE | Emory University (US) | 2025-05-21 | — | — | EP | disclosed |
| EP-3750544-B1 | JAK INHIBITORS FOR USE IN THE PREVENTION OR TREATMENT OF A VIRAL DISEASE CAUSED BY A CORONAVIRIDAE | UNIV EMORY (US) | 2025-03-05 | — | — | EP | disclosed |
| US-20250019418-A1 | SYSTEMS AND METHODS FOR THE PRODUCTION OF METHEMOGLOBIN AND ITS DERIVATIVES | OHIO STATE INNOVATION FOUNDATION | 2025-01-16 | — | — | US | disclosed |
| WO-2024055886-A1 | BRANCHED POLYETHYLENE GLYCOL LINKER AND USE THEREOF | 辽宁键凯科技有限公司 | 2024-03-21 | — | — | WO | disclosed |
| CN-115346689-B | Virus-drug association prediction method based on hypergraph self-adaptive inductive matrix completion | 厦门理工学院 | 2023-10-31 | — | — | CN | disclosed |
| US-20230225973-A1 | MULTI-LAYERED MEDICAMENT FOR INHALATION | MYLAN PHARMA UK LIMITED (GB) | 2023-07-20 | — | — | US | disclosed |
| CN-115505028-A | Branched polyethylene glycol linker and application thereof | 辽宁键凯科技有限公司 | 2022-12-23 | — | — | CN | disclosed |
| CN-115346689-A | Virus-drug association prediction method based on hypergraph adaptive induction matrix completion | 厦门理工学院 | 2022-11-15 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250019418-A1 | SYSTEMS AND METHODS FOR THE PRODUCTION OF METHEMOGLOBIN AND ITS DERIVATIVES | MB, HMBS, HCCS | ALDH1A1 1906/4885CA12 273/4885CA1 844/4885 |
| US-20230225973-A1 | MULTI-LAYERED MEDICAMENT FOR INHALATION | NDUFB5, NDUFB7, NDUFB8 | ALDH1A1 779/4885CA12 1630/4885CA1 3489/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.